The story of Viagra, formerly marketed by copyright, presents a fascinating case study for backers considering the drug landscape . Despite its early success and generation of vast in sales, the intellectual property lapse has opened the floodgates for alternative medications, significantly diminishing profit prospects . This shift raises questions